Acorah Software Products - Accounts Production 16.4.675 false true 31 October 2023 1 November 2022 false 1 November 2023 31 October 2024 31 October 2024 09734918 Mr Anand Shah Mrs Krutika Shah iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09734918 2023-10-31 09734918 2024-10-31 09734918 2023-11-01 2024-10-31 09734918 frs-core:CurrentFinancialInstruments 2024-10-31 09734918 frs-core:Non-currentFinancialInstruments 2024-10-31 09734918 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-10-31 09734918 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2023-11-01 2024-10-31 09734918 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2023-10-31 09734918 frs-core:ShareCapital 2024-10-31 09734918 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31 09734918 frs-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 09734918 frs-bus:FilletedAccounts 2023-11-01 2024-10-31 09734918 frs-bus:SmallEntities 2023-11-01 2024-10-31 09734918 frs-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 09734918 frs-bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 09734918 frs-core:UnlistedNon-exchangeTraded 2024-10-31 09734918 frs-core:UnlistedNon-exchangeTraded 2023-10-31 09734918 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-10-31 09734918 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-10-31 09734918 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-10-31 09734918 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-10-31 09734918 frs-bus:Director1 2023-11-01 2024-10-31 09734918 frs-bus:Director2 2023-11-01 2024-10-31 09734918 frs-countries:EnglandWales 2023-11-01 2024-10-31 09734918 2022-10-31 09734918 2023-10-31 09734918 2022-11-01 2023-10-31 09734918 frs-core:CurrentFinancialInstruments 2023-10-31 09734918 frs-core:Non-currentFinancialInstruments 2023-10-31 09734918 frs-core:ShareCapital 2023-10-31 09734918 frs-core:RetainedEarningsAccumulatedLosses 2023-10-31
Registered number: 09734918
Skar Pharma UK Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 09734918
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 - 184,494
Investments 5 670,048 670,048
670,048 854,542
CURRENT ASSETS
Debtors 6 50,000 75,004
Cash at bank and in hand 8,270 7,044
58,270 82,048
Creditors: Amounts Falling Due Within One Year 7 (286,071 ) (267,830 )
NET CURRENT ASSETS (LIABILITIES) (227,801 ) (185,782 )
TOTAL ASSETS LESS CURRENT LIABILITIES 442,247 668,760
Creditors: Amounts Falling Due After More Than One Year 8 (384,914 ) (617,002 )
NET ASSETS 57,333 51,758
CAPITAL AND RESERVES
Called up share capital 9 100 100
Profit and Loss Account 57,233 51,658
SHAREHOLDERS' FUNDS 57,333 51,758
Page 1
Page 2
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Anand Shah
Director
09/07/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Skar Pharma UK Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 09734918 . The registered office is 4 Nutter Lane, London, E11 2HY.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Freehold Freehold land is not depreciated
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
4. Tangible Assets
Land & Property
Freehold
£
Cost
As at 1 November 2023 184,494
Disposals (184,494 )
As at 31 October 2024 -
Net Book Value
As at 31 October 2024 -
As at 1 November 2023 184,494
5. Investments
Unlisted
£
Cost
As at 1 November 2023 670,048
As at 31 October 2024 670,048
Provision
As at 1 November 2023 -
As at 31 October 2024 -
Net Book Value
As at 31 October 2024 670,048
As at 1 November 2023 670,048
Page 3
Page 4
6. Debtors
2024 2023
£ £
Due within one year
Other debtors 50,000 50,000
Amounts owed by subsidiaries - 25,004
50,000 75,004
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Bank loans and overdrafts 70,018 55,788
Other creditors 214,299 210,242
Accruals and deferred income 1,500 1,800
Amounts owed to subsidiaries 254 -
286,071 267,830
8. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Bank loans 384,914 617,002
9. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 100 100
Page 4